Akebia Therapeutics to Report Third Quarter Financial Results and Highlight Recent Company Milestones

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) announced it will release its Q3 2022 financial results on November 3, 2022, after market close. A conference call is scheduled for the same day at 4:30 p.m. ET to discuss these results and recent company developments. The conference call can be accessed through a registration link provided in the announcement. Akebia, based in Cambridge, Massachusetts, is focused on improving the lives of those impacted by kidney disease.

Akebia to Host Conference Call to Provide Business Update

CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the third quarter ended September 30, 2022 on Thursday, November 3, 2022 following the close of financial markets.

Akebia will host a conference call on Thursday, November 3 at 4:30 p.m. ET to discuss its financial results and recent company highlights. To access the call by phone via a new process, please click on this Registration Link and you will be provided with dial in details. To avoid delays, we encourage dialing into the conference call fifteen minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-third-quarter-financial-results-and-highlight-recent-company-milestones-301660354.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia report its third quarter financial results for 2022?

Akebia will report its third quarter financial results on November 3, 2022.

What time is Akebia's conference call regarding the Q3 financial results?

The conference call is scheduled for November 3, 2022, at 4:30 p.m. ET.

How can I access the conference call for Akebia's financial results?

You can access the conference call by registering through the provided link to receive dial-in details.

Where can I find the webcast of Akebia's conference call?

The webcast will be available via the Investors section of Akebia's website.